Skip to content

The study of cardiovascular complications in osteogenesis imperfecta in adulthood

The study of cardiovascular complications in osteogenesis imperfecta in adulthood - The study of cardiovascular complications in osteogenesis imperfecta in adulthood

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041901
Enrollment
100
Registered
2020-09-27
Start date
2020-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteogenesis imperfecta

Interventions

None listed

Sponsors

Fukuoka Children's Hospital AIC Yaesu Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients between the ages of 30 and 79 years old who were diagnosed with osteogenesis imperfecta in a medical institution.

Exclusion criteria

Exclusion criteria: Patients who have received treatment for either cerebrovascular or cardiac disease. Other patients who are deemed by the investigators to be unsuitable as subjects

Design outcomes

Primary

MeasureTime frame
(A) Heart rate and blood pressure (B) Echocardiography (presence of valvular disease, left ventricular myocardial thickness, left ventricular diameter, left ventricular ejection fraction, aortic valve diameter, Valsalva sinus diameter, ST junction diameter, descending aorta diameter) (C) Head MRI and MRA (presence of cerebral aneurysm (defined as more than 2 mm) and size). Head MRI includes the evaluation of presence of basilar impression

Countries

Japan

Contacts

Public ContactYoshihiko Kodama

University of Miyazaki Hospital Department of pediatrics

kodamayoshihiko@gmail.com0985-85-0989

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026